首页 | 本学科首页   官方微博 | 高级检索  
检索        

5-FU加CF双周疗法联合腹腔化疗治疗晚期胃癌临床观察
引用本文:苏炳光,凌华晃,蔡茂德,黄锡梅.5-FU加CF双周疗法联合腹腔化疗治疗晚期胃癌临床观察[J].中华肿瘤防治杂志,2005,12(18):1391-1393.
作者姓名:苏炳光  凌华晃  蔡茂德  黄锡梅
作者单位:广东省高州市人民医院(广东医学院高州临床学院)化疗科,广东,高州,525200;广东省高州市人民医院(广东医学院高州临床学院)化疗科,广东,高州,525200;广东省高州市人民医院(广东医学院高州临床学院)化疗科,广东,高州,525200;广东省高州市人民医院(广东医学院高州临床学院)化疗科,广东,高州,525200
摘    要:目的:探讨5-氟尿嘧啶(5-FU) 醛氢叶酸(CF)双周疗法联合顺铂(DDP)、依托泊苷(Vp-16)腹腔化疗治疗晚期胃癌的疗效及不良反应。方法:103例患者按数字随机法分两组。观察组54例:CF200mg/m2,静脉滴入,后经留置中心静脉导管48h持续灌注高浓度5-FU3g/m2,腹腔化疗DDP80mg/m2、Vp-16200mg/m2,每2周重复。对照组49例:CF200mg/d、5-FU500mg/(m2·d),静脉滴入,d1~d5,DDP20mg/(m2·d)、Vp-1670mg/(m2·d),静脉滴入,d1~d4,每3周重复。结果:观察组和对照组有效率分别为64·8%和44·9%,KPS评分增高率分别为74·1%和53·1%,中位生存期分别为13和8·5个月,1年生存率分别为48·1%、38·8%,有效率及KPS评分增高率差异有统计学意义,P<0·05。两组骨髓毒性及消化道反应相似,P>0·05,观察组静脉炎、口腔黏膜炎明显减轻。结论:5-FU CF双周疗法联合腹腔化疗对晚期胃癌有效率高,不良反应较轻,生存质量提高。

关 键 词:5-氟尿嘧啶/治疗应用  醛氢叶酸/治疗应用  胃肿瘤/药物疗法  药物疗法  联合
文章编号:1009-4571(2005)18-1391-03
修稿时间:2005年1月20日

Treatment of advanced gastric carcinoma with 5 fluorouracil plus leucovorin biweekly schedule combined with intraperitoneal chemotherapy
SU Bing-guang,LING Hua-huang,CAI Mao-de,Huang Xi-mei.Treatment of advanced gastric carcinoma with 5 fluorouracil plus leucovorin biweekly schedule combined with intraperitoneal chemotherapy[J].Chinese Journal of Cancer Prevention and Treatment,2005,12(18):1391-1393.
Authors:SU Bing-guang  LING Hua-huang  CAI Mao-de  Huang Xi-mei
Abstract:OBJECTIVE:To evaluate the efficacy and safety of 5-fluorouracil plus leucovorin biweekly schedule treatment combined with cisplatin,etoposide intraperitoneal chemotherapy on advanced gastric carcinoma.METHODS: A total of 103 cases of advanced gastric carcinoma were randomized into two groups:1) 54 patients in the treatment group of biweekly schedule combined with intraperitoneal chemotherapy: affusing continually high consistency 5-fluorouracil by retained central venous catheter for 48 hours after intravenous dripping leucovorin. Intraperitoneal chemotherapy with cisplatin and etoposide, every 2 weeks repeated; 2) 49 patients in the control group of conventional intravenous chemotherapy: intravenous dripping for five days with 5-fluorouracil plus leucovorin and four days with cisplatin plus etoposide, every 3 weeks repeated. RESULTS: The response rates in the treatment group and the control group were 64.8% and 44.9% respectively. The improvement rates of Karnofsky performance score were 74.1% and 53.1% respectively. The median survival time were 13 months and 8.5 months respectively. The 1-year survival rates were 48.1% and 38.8% respectively. Comparing the rates of response and Karnofsky performance score (P<0.05), there were statistically significant differences. The myelosuppression and alimentary tract reactions were similar, P>0.05.The phlebitis and stomatitis in the treatment group mitigated obviously.CONCLUSIONS: The response rate in the treatment by 5-fluorouracil plus leucovorin biweekly schedule combined with cisplatin and etoposide intraperitoneal chemotherapy is higher to advanced gastric carcinoma. The toxicities were not serious. The quality of the pationts was improved.
Keywords:5-fluorouracil /theropeutic use  leucovorin/theropeutic use  gastric neoplasms/drug therapy  drug therapy  combination
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号